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Helicobacter pylori 26695, a highly pathogenic bacterium, is a 
human gastric epithelia colonizer, correlated with the 
development of duodenal and gastric ulcers, and gastric 
cancer worldwide. Its genome has been previously sequenced 
and annotated, and two genome-scale metabolic models 
have been developed; however, since their publication, vast 
amounts of data and new methodologies have been 
developed. In order to maintain accurate and relevant the 
information on this bacterium, and to generate new 
information and new approaches for its analysis, the 
assignment of new functions to H. pylori 26695’s genes was 
performed and a new genome-scale metabolic model was 
reconstructed. 
This work originated the iTR383 metabolic model, a 
compartmentalized model containing 383 genes and 
composed by 640 different reactions and 412 metabolites. 
Gene essentiality analysis and growth simulations were 
performed using experimental data and nutrient uptake rates 
to assess the predictive capabilities of the model. Metabolite 
and flux distribution in the central carbon metabolism 
pathway using different carbon sources were analyzed, as 
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well as pathways for non-essential amino acids biosynthesis, 
the nitric oxide influx effect, and electron transport and 
respiratory chain. 
This model accurately predicts H. pylori’s phenotypic 
response to different carbon sources and is in agreement with 
experimental results obtained in minimal and complex media. 
We believe that this work represents a significant advance in 
understanding H. pylori 26695’s metabolism and will provide 
relevant biological information to the scientific community 
working on new approaches for enhanced treatments. 
 
